Join
Live feed
·
INSIDERFilingvia Quantisnow
Chinook Therapeutics Inc. logo

SEC Form 4: Jerel Davis disposed of 974,918 shares and acquired 31,604 shares, increasing direct ownership by 0.45% to 737,875 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KDNY (Chinook Therapeutics Inc.) and more on Quantisnow.